Institutional Research Division

Keyphrases

1. Aging 14%
2. Alcohol 7%
3. Alzheimer's Disease 8%
4. Anxiety Sensitivity 12%
5. Atlantic Canada 6%
6. Atrial Fibrillation 6%
7. Attention Deficit Hyperactivity Disorder 6%
8. Autism 7%
9. Autism Spectrum Disorder 13%
10. Bipolar Disorder 12%
11. Canada 100%
12. Canadian Provinces 6%
13. Cannabis 6%
14. Childhood Autism 10%
15. Chronic Obstructive Pulmonary Disease 8%
16. Chronic Pain 7%
17. Climate Change 7%
18. Clinical Practice 7%
19. Clinical Practice Guidelines 7%
20. Clinical Trials 6%
21. Comorbidity 7%
22. Confidence Interval 36%
23. Controller 6%
24. COVID-19 14%
25. COVID-19 Pandemic 15%
26. Deep Vein Thrombosis 10%
27. Deficit Accumulation 8%
28. Dementia 8%
29. Depressive Symptoms 9%
30. Diabetes 8%
31. Drinking Motives 7%
32. During Pregnancy 6%
33. Electrolyte 9%
34. Electrolyte Additive 10%
35. Emergency Department 11%
36. Emergency Medicine 7%
37. Eukaryotes 7%
38. Evidence-based 6%
39. Family Physicians 6%
40. Finite-difference Time-domain Method 7%
41. Frailty 32%
42. Frailty Index 18%
43. Fruit Yield 6%
44. Genetic Programming 6%
45. Glaucoma 6%
46. Graphite 16%
47. Halifax 12%
48. Health Systems 11%
49. Health-related Quality of Life 9%
50. Healthcare Professionals 15%
51. High Risk 11%
52. Hospitalization 9%
53. Hypertension 6%
54. Illness 8%
55. Immunization 15%
56. Immunogenicity 13%
57. Inflammatory Bowel Disease 7%
58. Influenza 9%
59. Influenza Vaccine 7%
60. Inhibition of Return 8%
61. Iran 8%
62. Li-ion 8%
63. Machine Learning 6%
64. Major Depressive Disorder 8%
65. Mental Health 11%
66. Meta-analysis 21%
67. North America 6%
68. Nova Scotia 54%
69. Obesity 7%
70. Odds Ratio 8%
71. Older Adults 28%
72. Pediatric 7%
73. Perfectionism 10%
74. Pertussis 8%
75. Physeter Macrocephalus 7%
76. Physical Activity 19%
77. Placebo 9%
78. Population-based Study 7%
79. Pouch Cell 13%
80. Pregnant Women 6%
81. Primary Care 14%
82. Randomized Controlled Trial 19%
83. Randomized Trial 9%
84. Resilience 12%
85. Risk Factors 9%
86. Scoping Review 15%
87. Sexual Behavior 6%
88. Sexual Satisfaction 8%
89. Socioeconomic Inequalities 11%
90. Sperm Whale 14%
91. Systematic Meta-analysis 9%
92. Systemic Lupus Erythematosus 7%
93. Three-dimensional (3D) 7%
94. United States 9%
95. Vaccination 10%
96. Vinylene Carbonate 6%
97. Warfarin 6%
98. Well-being 8%
99. Whale 6%
100. Wild Blueberry 12%